CATALYST PHARMACEUTICALS INC

Ticker: CPRX CUSIP: 14888U101 Class: Common Stock

Hillsdale Investment Management Inc.'s Holding History (CIK: 0001368465)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 243,500 Value ($000) $4,797 Avg Close $20.57 Range $19.05 - $22.53

Q2 2025

Shares 264,800 Value ($000) $5,746 Avg Close $23.61 Range $20.40 - $26.58

Q1 2025

Shares 197,100 Value ($000) $4,780 Avg Close $22.52 Range $19.15 - $26.16

Q4 2024

Shares 190,000 Value ($000) $3,965 Avg Close $21.48 Range $19.54 - $24.27

Q3 2024

Shares 189,900 Value ($000) $3,775 Avg Close $18.54 Range $14.97 - $21.67

Q4 2023

Shares 280 Value ($000) $5 Avg Close $13.67 Range $11.55 - $17.40

Q3 2023

Shares 360 Value ($000) $4 Avg Close $13.38 Range $11.59 - $15.59

Q2 2023

Shares 255,320 Value ($000) $3,432 Avg Close $14.39 Range $11.09 - $18.22

Q1 2023

Shares 335,900 Value ($000) $5,569 Avg Close $16.50 Range $13.30 - $22.11

Q4 2022

Shares 359,800 Value ($000) $6,692 Avg Close $15.40 Range $12.08 - $19.78

Q3 2022

Shares 481,700 Value ($000) $6,180 Avg Close $11.85 Range $6.87 - $17.22

Q2 2022

Shares 655,600 Value ($000) $4,595 Avg Close $7.33 Range $6.15 - $8.65

Q1 2022

Shares 649,900 Value ($000) $5,388 Avg Close $7.07 Range $5.24 - $8.64

Q4 2017

Shares 17,000 Value ($000) $66 Avg Close $3.30 Range $2.41 - $4.51

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	243,500	$4,797	$20.57	$19.05 - $22.53
Q2 2025	264,800	$5,746	$23.61	$20.40 - $26.58
Q1 2025	197,100	$4,780	$22.52	$19.15 - $26.16
Q4 2024	190,000	$3,965	$21.48	$19.54 - $24.27
Q3 2024	189,900	$3,775	$18.54	$14.97 - $21.67
Q4 2023	280	$5	$13.67	$11.55 - $17.40
Q3 2023	360	$4	$13.38	$11.59 - $15.59
Q2 2023	255,320	$3,432	$14.39	$11.09 - $18.22
Q1 2023	335,900	$5,569	$16.50	$13.30 - $22.11
Q4 2022	359,800	$6,692	$15.40	$12.08 - $19.78
Q3 2022	481,700	$6,180	$11.85	$6.87 - $17.22
Q2 2022	655,600	$4,595	$7.33	$6.15 - $8.65
Q1 2022	649,900	$5,388	$7.07	$5.24 - $8.64
Q4 2017	17,000	$66	$3.30	$2.41 - $4.51